U.S. Representative Jackie Walorski (R-Ind.) today introduced the Safeguarding Women’s and Children’s Health Act of 2022, which would require more accurate reporting of abortion drug prescribing and related adverse side effects and events.
“As chemical abortions become more frequent, American women need to know the risks of abortion pills such as mifepristone. While the Biden Administration’s FDA recklessly removes guardrails on chemical abortion drug prescribing, too many of the facts are unknown. Women who take abortion drugs are ending up in emergency rooms – or worse,” said Congresswoman Walorski. “Dangerous abortion pill side effects are killing women and their children. We can’t allow deadly complications to fly under the radar. The American people need to know the truth. The Safeguarding Women’s and Children’s Health Act will strengthen transparency at the FDA and expose the true cost of these drugs.”
Current law lacks mandatory reporting of abortion drug adverse events, leaving accurate statistics and data unknown. The Safeguarding Women’s and Children’s Health Act would require health care providers – including abortion providers and the emergency medical professionals who most often treat women following a botched chemical abortion – to report any death or adverse event related to abortion drugs to both the U.S. Food and Drug Administration (FDA) and the drug manufacturer. It would also require that all information compiled on these drugs be made publicly and easily accessible on the FDA’s website.
Congresswoman Walorski’s legislation has garnered the support of prominent pro-life groups, including the Susan B. Anthony (SBA) List, Family Research Council, National Right to Life, and the U.S. Conference of Catholic Bishops.
“Chemical abortion drugs endanger women’s health and safety as well as the lives of countless unborn children. Real-world data shows the rate at which abortion pills send women to the emergency room has increased more than 500% since the early 2000s – more than 20 women have even died. Under Obama and now Biden, safety standards and data on life-threatening complications have been deliberately weakened and every effort made to expand mail-order abortion drugs while downplaying the risks. We thank Congresswoman Walorski for exposing this reckless agenda and continually standing up for women and children,” said Hon. Marilyn Musgrave, VP of Gov Affairs, SBA List.
“The pro-abortion movement is dishonest about the impact of chemical abortion on a woman’s physical and mental health. Our own federal government does little to keep track of the health complications related to chemical abortion, with only states and independent researchers documenting the dangers of this drug. Thanks to the leadership of Rep. Walorski we have the opportunity to collect more complete and transparent data on just how abortion drugs negatively impact the women who take them,” said Mary Szoch, Director of the Center for Human Dignity, Family Research Council.
“National Right to Life commends Rep. Jacki Walorski on introducing the ‘Safeguarding Women’s and Children’s Health Act of 2022.’ This important legislation would strengthen much needed reporting on the complications associated with chemical abortion drugs. With the rapid shift toward chemical abortions, the current reporting requirements of complications associated with them, particularly with the newly authorized telemedical abortions, are woefully inadequate. We applaud the Congresswoman for her commitment to protecting not only unborn children, but also their mothers,” said Carol Tobias, President, National Right to Life.
Original co-sponsors of the Safeguarding Women’s and Children’s Health Act include Rep. Jim Banks, Rep. David McKinley, Rep. Billy Long, Rep. Jeff Duncan, Rep. Alex Mooney, Rep. Doug Lamborn, Rep. John Curtis, Rep. Richard Hudson, Rep. Jake Ellzey, Rep. Brian Babin, Rep. Mariannette Miller-Meeks, Rep. Virginia Foxx, Rep. Tim Burchett, Rep. Michael Burgess, M.D., Rep. Randy Feenstra, Rep. John Joyce, M.D., Rep. Doug LaMalfa, Rep. Scott Franklin, Rep. Michelle Fischbach, and Rep. Blaine Luetkemeyer.
Read the full text HERE.
Walorski represents the 2nd Congressional District of Indiana, serving as a member of the House Ways and Means Committee and the Ranking Member of the House Ethics Committee.